Nanjing Saiteng biotechnology companies to develop health food project

Spring Festival approaching, the health care market has entered a shopping season. At the same time, held in early January, mainstream business and industry experts gathered for the second derivative of the General Assembly, the participants reached the same conclusion, in 2016 derivative of nutraceuticals market, policy changes and changes in consumption trends Under the tide, will enter a new stage of development, the industry will be a new feature, the market size is expected to emerge a new round of growth, listed companies doing my part to become the industry leader in innovation.

2016 will be the old and the new management system of alternating years, cross-border electricity supplier, investment acquisitions, category brand, the rural market heating up and formulas for special medical purposes birth these five elements, will effectively promote the derivative industry progress, and formula for special medical purposes Food will be the first element of the development impact of derivative industry. Meanwhile, health care products market, there have been five new features: First, the reform of the management system will stimulate capital inflows, appears the industry's most active mergers and acquisitions wave ever; secondly, the cross-border electricity supplier supply chain worldwide, cross-border shopping formats molding force market change the competitive landscape; health needs of rural areas by the Internet wakes up, seize the third terminal pharmaceutical companies selling health products; special health food management system introduced, a solid scientific and technological base of enterprises will seize the initiative; and finally, the collective enterprise of raw materials to downstream expansion, category brand into market trends.

Nanjing Saiteng Biotechnology Co., Ltd. is a company specializing in health products and services provider, the company team with 20 years of industry precipitation, as well as domestic and foreign R & D team, to provide customers with customized, from raw material acquisition, extraction, formulation design to a finished product stop service. Currently, the company has reached the United States GMP standards, and in strict compliance with Chinese GMP standards for the whole process of standardization management. Have NSF, BRC, TGA, HALAL, FDA, ISO22000 and HACCP certificate. Customers in Europe, Southeast Asia, China, Australia and the Americas, is well-known brands of health services has reached more than 100, and was well received at home and abroad customers.

Nanjing Saiteng Biotech Ltd, said, "Our country promising health care products market, traditional companies are also actively restructuring. The company also defected from medicine to nutrition and health food industry, if we can seize the opportunity to develop a great health care industry hope. Now, health care, consumer groups are increasingly inclined 'younger faction', 30-year-old to 45-year-old consumer health products has become a very large potential consumer groups. "Saiteng Biotechnology Co., Ltd. in the full market research basic advantage of relying on local resources, the introduction of a health food Derivative channel expansion project, which is green and healthy for the concept, R & D, production and health series of high-end products.

Products within the project include Isabel SLAB carnitine coffee, healthy leaven source enzymes, beneficial send Charisma coffee sheet, chia seed, a comprehensive put into production, can achieve an annual benefit send 50 million pieces Charisma coffee, health 200,000 bottles of yeast enzyme source. Nanjing Saiteng Biotech Ltd, who believes that "Saiteng give positive energy society, in the current health care industry credibility, social evaluation of the situation is not too high, we should first check the quality of products, improve the technological content . "The project since its inception in 2015, in the derivative market steadily. This project will also undertake pilot study functionally related scientific research, and by means of technology platforms and the Group's brand to attract domestic and foreign outstanding enterprises and university institutes to carry out technical exchanges and cooperation, the introduction of high-tech, high value-added products for local make new and greater contributions to economic development.